&lt;Organon International BV>, asubsidiary of the pharmaceutical division of Dutch chemicalgroup Akzo NV &lt;AKZO.AS>, said it agreed to cooperate in drugresearch and development with &lt;California Biotechnology Inc>.    Organon will receive world clinical development andmarketing rights for any products pioneered under the agreementwith the U.S. Firm, an Organon spokesman said. He gave nofurther details.    The two companies will be looking at drugs to treatailments of the nervous system like Alzheimer's disease whichoften affects the elderly, he said. REUTER&#3;